Maze Therapeutics, Inc.
USD28.43
+1.41 (+5.22%)
CEO
Jason Coloma
IPO Date
2025-01-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$27.02
Prev. Close
$27.02
Day Low
$26.71
Day High
$29.93
52W Low
$10.98
52W High
$53.65
Market Cap
$1.57B
Volume
1.63M
| 2,040 |
| $26.00 |
| 24 Jun 2026 | Coloma Jason V | director, officer: Chief Executive Officer | S-Sale | Disposed | 23,865 | $26.05 |
| 10 Jun 2026 | SPIEGELMAN DANIEL K | director | A-Award | Acquired | 18,000 | $23.58 |
| 10 Jun 2026 | SCHELLER RICHARD H | director | A-Award | Acquired | 18,000 | $23.58 |
| 10 Jun 2026 | Lim Jonathan E | director | A-Award | Acquired | 18,000 | $23.58 |
| 10 Jun 2026 | Hoppenot Herve | director | A-Award | Acquired | 18,000 | $23.58 |
| 10 Jun 2026 | HOMCY CHARLES J | director | A-Award | Acquired | 18,000 | $23.58 |
| 10 Jun 2026 | Andrews Nancy C | director | A-Award | Acquired | 18,000 | $23.58 |
| 3 Jun 2026 | Coloma Jason V | director, officer: Chief Executive Officer | S-Sale | Disposed | 6,090 | $26.20 |